ABVX Stock Analysis: Buy, Sell, or Hold?
ABVX - Abivax SA American Depositary Shares
$111.46
0.31 (0.28%)
▲
5d:
-7.79%
30d:
-17.35%
90d:
+6.88%
HOLD
MODERATE Confidence
Last Updated: February 2, 2026
Earnings: Mar 23, 2026
Get Alerted When ABVX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ABVX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: ABVX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: ABVX is currently trading at $111.46, which is considered oversold relative to its 30-day fair value range of $113.50 to $131.16.
Technical Outlook: Technically, ABVX is in a strong uptrend. Immediate support is located at $107.42, while resistance sits at $125.86.
Market Sentiment: ABVX has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $123.78 (+11.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ABVX is in a strong uptrend. Immediate support is located at $107.42, while resistance sits at $125.86.
Market Sentiment: ABVX has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $123.78 (+11.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$113.50 -
$131.16
Company Quality Score
46/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
55.3%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($123.78)
- CAUTION: 5-day price weakness (-7.8%) - monitor closely
Fair Price Analysis
30-Day Fair Range
$113.50 -
$131.16
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$107.42
Resistance Level
$125.86
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-38.15
Wall Street Target
$123.78
(+11.1%)
Revenue Growth (YoY)
-81.3%
Last updated: February 02, 2026 6:16 PM ET
Data refreshes hourly during market hours. Next update: 7:16 PM
Data refreshes hourly during market hours. Next update: 7:16 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ABVX showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$91 | 61 BUY |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$117 | 61 BUY |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$140 | 52 HOLD |
|
VRDN
Viridian Therapeutics Inc |
STRONG BUY
16 analysts |
$42 | 65 BUY |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$30 | 53 HOLD |
